INT236397
From wiki-pain
|
|
|
|
|
Sentences Mentioned In
Key: | Protein | Mutation | Event | Anatomy | Negation | Speculation | Pain term | Disease term |
Furthermore, VEGF-A mutants that bind selectively to FLK-1 are able to induce mitogenesis and chemotaxis in endothelial cells, and vascular permeability and angiogenesis in vivo, whereas VEGF-A mutants that selectively bind to FLT-1 do not have the activities stated above (29,30). | |||||||||||||||
| |||||||||||||||
|
It has been suggested that Flt1 may protect VEGF from proteolytic degradation by binding to it in the ECM [33]. | |||||||||||||||
| |||||||||||||||
|
In this case Cyclo-VEGI binding to VEGFR-1 in activated microglia could inhibit cellular reactivity and VEGF production leading to a reduced vascular permeability for fibrinogen infiltration into striatum. | |||||||||||||||
| |||||||||||||||
|
VEGF-A binds both VEGFR-1 and VEGFR-2, while PlGF and VEGF-B interact only with VEGFR-1. | |||||||||||||||
| |||||||||||||||
|
VEGF is one of the signaling molecules that binds to its receptors on cell membrane, VEGFR1 and VEGFR2, initiating signaling pathways through Akt activation. | |||||||||||||||
| |||||||||||||||
|
General Comments
This test has worked.